Nautilus Biotechnology, Inc. (NAUT)Stock Price & Financial Statements
AboutNautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.Show more
- Revenue $0
- EBITDA $0 +100.0%
- Net Income -$59M +16.6%
- EPS (Diluted) -0.47 +16.1%
- Gross Margin -
- EBITDA Margin -
- Operating Margin -
- Net Margin -
- ROE -32.27% -8.1%
- ROIC -
- Debt/Equity 0.19 +31.0%
- Interest Coverage -
Key Insights
Based on financial data analysisStrengths
- ✓Momentum leader: RS Rating 96 (top 4%)
Weaknesses
- ✗Weak Piotroski F-Score: 1/9
- ✗Low asset turnover indicates capital-intensive operations
Price & Volume
Loading chart...
Growth Metrics
Revenue CAGR
10Y-
5Y-
3Y-
TTM-
Profit (Net Income) CAGR
10Y-
5Y-
3Y-
TTM10.53%
EPS CAGR
10Y-
5Y-
3Y-
TTM10.71%
ROCE
10Y Avg-30.49%
5Y Avg-23.26%
3Y Avg-27.23%
Latest-
Peer Comparison
Diagnostics and Omics Tools| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
 VCYTVeracyte, Inc. | 2.88B | 36.27 | 44.23 | 16.01% | 12.83% | 5.07% | 4.4% | 0.03 |
 ASBPWAspire Biopharma Holdings, Inc. | 178.9K | 0.02 | -0.01 | -16351.77% | ||||
 VRAXVirax Biolabs Group Limited | 1.55M | 0.21 | -0.11 | -95.95% | -78.62% | -234.24% | 0.07 | |
 CDIOCardio Diagnostics Holdings, Inc. | 141.46M | 5.26 | -0.57 | 104.45% | -415.16% | -80.38% | 0.10 | |
 AIMDAinos, Inc. | 7.24M | 1.51 | -0.97 | -83.02% | -132.32% | -148.9% | 0.77 | |
 IMDXInsight Molecular Diagnostics Inc. | 95.47M | 5.47 | -1.17 | 25.15% | -13.81% | -14.81% | ||
 SEERSeer, Inc. | 103.2M | 1.85 | -1.33 | -8.13% | -486.02% | -29.19% | 0.08 | |
 ASBPAspire Biopharma Holdings, Inc. | 62.88M | 1.32 | -5.08 | -16351.99% |
Compare NAUT vs Peers
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
Income Statement
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 2.35M | 2.84M | 3.42M | 5.71M | 6.35M | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | -2.35M | -2.84M | -3.42M | -5.71M | -6.35M | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | -21.14% | -20.2% | -67.01% | -11.36% | 100% |
| Operating Expenses | 111.68M | 10.11M | 13.4M | 47.66M | 60.2M | 70.45M | 75.12M | 66.84M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 111.68M | 1.62M | 3.31M | 21.15M | 23.75M | 28.9M | 31M | 25.73M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - |
| Research & Development | 0 | 8.49M | 10.09M | 26.51M | 36.45M | 47.25M | 50.48M | 41.11M |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -5.71M | -6.35M | 0 |
| Operating Income | -111.68M | -10.11M | -15.74M | -50.5M | -63.62M | -76.15M | -81.48M | 0 |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | 90.95% | -55.73% | -220.74% | -25.98% | -19.7% | -6.99% | 100% |
| EBITDA | 626.6M | -9.56M | -13.4M | -47.66M | -60.2M | -74.3M | -75.12M | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| EBITDA Growth % | - | -101.53% | -40.12% | -255.69% | -26.33% | -23.42% | -1.1% | 100% |
| D&A (Non-Cash Add-back) | 738.28M | 548K | 2.35M | 2.84M | 3.42M | 1.85M | 6.35M | 0 |
| EBIT | -111.68M | -10.11M | -15.62M | -50.31M | -57.92M | -76.15M | -70.78M | 0 |
| Net Interest Income | 0 | 0 | 0 | 329K | 0 | 12.55M | 10.78M | 0 |
| Interest Income | 0 | 0 | 0 | 329K | 5.82M | 12.55M | 10.78M | 7.87M |
| Interest Expense | 0 | 0 | 0 | 0 | 5.82M | 0 | 0 | 0 |
| Other Income/Expense | 738.28M | 492K | 125K | 183K | 5.69M | 12.48M | 10.7M | 0 |
| Pretax Income | 626.6M | -9.62M | -15.62M | -50.31M | -57.92M | -63.67M | -70.78M | -59M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Net Income | 626.6M | -9.62M | -15.62M | -50.31M | -57.92M | -63.67M | -70.78M | -59M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | -101.53% | -62.39% | -222.14% | -15.12% | -9.93% | -11.16% | 16.64% |
| Net Income (Continuing) | 626.6M | -9.62M | -15.62M | -50.31M | -57.92M | -63.67M | -70.78M | -59M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 87.18 | -1.59 | -0.47 | -0.60 | -0.46 | -0.51 | -0.56 | -0.47 |
| EPS Growth % | - | -101.82% | 70.44% | -27.66% | 23.33% | -10.87% | -9.8% | 16.07% |
| EPS (Basic) | 87.18 | -1.59 | -0.47 | -0.60 | -0.46 | -0.51 | -0.56 | -0.47 |
| Diluted Shares Outstanding | 7.19M | 6.07M | 33.07M | 84.46M | 124.59M | 124.92M | 125.43M | 126.26M |
| Basic Shares Outstanding | 7.19M | 6.07M | 33.07M | 84.46M | 124.59M | 124.92M | 125.43M | 126.26M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Balance Sheet
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.33M | 16.96M | 77.66M | 349.22M | 187.21M | 176.84M | 132.83M | 105.96M |
| Cash & Short-Term Investments | 144.49B | 16.66M | 76.74M | 345.73M | 184.47M | 173.42M | 129.89M | 103.41M |
| Cash Only | 1.2M | 595K | 36.61M | 185.62M | 114.52M | 19.4M | 27.65M | 12.39M |
| Short-Term Investments | 144.49B | 16.06M | 40.13M | 160.11M | 69.95M | 154.02M | 102.25M | 91.02M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | -144.49B | 0 | 0 | 0 | 0 | 3.42M | 2.93M | 2.56M |
| Total Non-Current Assets | 144.49M | 1.58M | 7.35M | 49.23M | 162.84M | 128.73M | 109.92M | 85.15M |
| Property, Plant & Equipment | 0 | 1.12M | 6.21M | 31.86M | 32.57M | 36.9M | 32.33M | 31.23M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 144.49M | 0 | 0 | 16.37M | 129.17M | 90.65M | 76.41M | 52.74M |
| Other Non-Current Assets | 0 | 459K | 1.14M | 997K | 1.11M | 1.18M | 1.18M | 1.18M |
| Total Assets | 145.82M | 18.54M | 85.01M | 398.45M | 350.05M | 305.56M | 242.74M | 191.11M |
| Asset Turnover | - | - | - | - | - | - | - | - |
| Asset Growth % | - | -87.28% | 358.48% | 368.7% | -12.15% | -12.71% | -20.56% | -21.27% |
| Total Current Liabilities | 5K | 490K | 3.02M | 5.81M | 6.79M | 9.12M | 7.63M | 7.95M |
| Accounts Payable | 0 | 289K | 470K | 1.72M | 1.27M | 1.64M | 987K | 943K |
| Days Payables Outstanding | - | - | 73.12 | 221.29 | 135.91 | 104.86 | 56.71 | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.83M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5K | 77K | 617K | 388K | 438K | 2.97M | 2.55M | 4.12M |
| Current Ratio | 266.45x | 34.62x | 25.73x | 60.09x | 27.57x | 19.39x | 17.40x | 13.33x |
| Quick Ratio | 266.45x | 34.62x | 25.73x | 60.09x | 27.57x | 19.39x | 17.40x | 13.33x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 5M | 275M | 111.71M | 29.06M | 28.34M | 31.09M | 26.38M | 26.19M |
| Long-Term Debt | 5M | 275M | 0 | 0 | 0 | 0 | 0 | 26.19M |
| Capital Lease Obligations | 0 | 0 | 3.3M | 29.06M | 28.34M | 31.09M | 26.38M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 108.42M | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 140.82M | 490K | 114.73M | 34.87M | 35.13M | 40.21M | 34.01M | 34.14M |
| Total Debt | 5M | 275M | 4.78M | 30.03M | 30.33M | 34.63M | 30.48M | 30.02M |
| Net Debt | 3.8M | 274.4M | -31.83M | -155.59M | -84.19M | 15.23M | 2.83M | 17.63M |
| Debt / Equity | 1.00x | 15.23x | - | 0.08x | 0.10x | 0.13x | 0.15x | 0.19x |
| Debt / EBITDA | 0.01x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.01x | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -10.94x | - | - | - |
| Total Equity | 5M | 18.05M | -29.72M | 363.58M | 314.92M | 265.35M | 208.73M | 156.97M |
| Equity Growth % | - | 261.04% | -264.64% | 1323.3% | -13.38% | -15.74% | -21.34% | -24.8% |
| Book Value per Share | 0.70 | 2.98 | -0.90 | 4.30 | 2.53 | 2.12 | 1.66 | 1.24 |
| Total Shareholders' Equity | 5M | 18.05M | -29.72M | 363.58M | 314.92M | 265.35M | 208.73M | 156.97M |
| Common Stock | 0 | 1K | 1K | 12K | 12K | 13K | 13K | 13K |
| Retained Earnings | 626.6K | -14.71M | -30.32M | -80.64M | -138.56M | -202.24M | -273.02M | -332.02M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 7K | 3K | -184K | -1.85M | -255K | 57K | 243K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow Statement
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -238.3M | -9.66M | -14M | -39.24M | -45.81M | -51.71M | -59.15M | -50.7M |
| Operating CF Margin % | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | 95.95% | -44.86% | -180.37% | -16.73% | -12.89% | -14.38% | 14.29% |
| Net Income | 626.6M | -9.62M | -15.62M | -50.31M | -57.92M | -63.67M | -70.78M | -59M |
| Depreciation & Amortization | 0 | 548K | 2.35M | 2.84M | 3.42M | 5.71M | 6.35M | 6.46M |
| Stock-Based Compensation | 0 | 110K | 369K | 7.93M | 10.38M | 12.14M | 12.7M | 6.84M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -866.23M | -157K | 295K | 320K | -890K | -2.66M | -1.96M | -5M |
| Working Capital Changes | 1.33M | -545K | -1.39M | -22K | -788K | -3.22M | -5.46M | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 123K | 1.26M | -561K | 393K | -578K | -69K |
| Cash from Investing | 1.2M | 4.05M | -25.28M | -138.96M | -25.74M | -43.73M | 66.25M | 35.22M |
| Capital Expenditures | 0 | -926K | -921K | -2.27M | -2.32M | -2.44M | -2.12M | -1.28M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 1.2M | 4.98M | 0 | 0 | 0 | 0 | 154.65M | 108.99M |
| Cash from Financing | 145.19B | 36K | 75.9M | 327.45M | 562K | 368K | 1.14M | 214K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 1000K | -1000K | 562K | 368K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -1.2M | -874.33K | 0 | 0 | 0 | 0 | 0 | 156K |
| Other Financing | 145.19B | 36K | 42K | 335.41M | 0 | 0 | 0 | 214K |
| Net Change in Cash | 1.2M | 595K | 36.62M | 149.24M | -70.98M | -95.08M | 8.25M | -15.26M |
| Free Cash Flow | -238.3M | -10.59M | -14.92M | -41.51M | -48.13M | -54.15M | -61.27M | -51.97M |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF Growth % | - | 95.56% | -40.89% | -178.27% | -15.95% | -12.51% | -13.14% | 15.17% |
| FCF per Share | -33.15 | -1.75 | -0.45 | -0.49 | -0.39 | -0.43 | -0.49 | -0.41 |
| FCF Conversion (FCF/Net Income) | -0.38x | 1.00x | 0.90x | 0.78x | 0.79x | 0.81x | 0.84x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Key Ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 12532% | -83.45% | - | -30.14% | -17.07% | -21.95% | -29.86% | -32.27% |
| Return on Invested Capital (ROIC) | - | -5.03% | -10.23% | -51.73% | -21.75% | -22.34% | -24.83% | - |
| Debt / Equity | 1.00x | 15.23x | - | 0.08x | 0.10x | 0.13x | 0.15x | 0.19x |
| Interest Coverage | - | - | - | - | -10.94x | - | - | - |
| FCF Conversion | -0.38x | 1.00x | 0.90x | 0.78x | 0.79x | 0.81x | 0.84x | 0.86x |
Deep Dive Analysis
Explore detailed financial history, valuation models, and returns analysis
Valuation Overview
DCF models, peer multiples & analyst estimates
Total Return Calculator
Historical returns with dividends reinvested
Dividend History
Yield, growth, payout safety & DRIP calculator
Earnings History
EPS trends, net income & profitability analysis
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of valuation, profitability & efficiency metrics